Wellinghoff Darryl 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 13, 2020
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-09+30,000→ 30,000 totalExercise: $5.25Exp: 2030-01-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.